Want to see CON full AI Analyst Report?
Concentra Group Holdings Parent, Inc. (CON) AI Stock Analysis
Concentra Group Holdings Parent, Inc.
(NYSE:CON)
CON’s score is supported by strong technical momentum and a very positive earnings update with raised guidance and margin/volume strength. Financial performance is solid with good cash conversion, but the overall profile is held back by elevated balance-sheet leverage risk and a valuation (P/E ~24.9 with a low dividend yield) that leaves less room for execution missteps.
Concentra Group Holdings Parent, Inc. Key Performance Indicators (KPIs)
Concentra Group Holdings Parent, Inc. (CON) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $5.36B
- Dividend Yield
- 0.59%
- Average Volume (3M)
- 1.09M
- Price to Earnings (P/E)
- 24.9
- Beta (1Y)
- 0.60
- Revenue Growth
- 14.02%
- EPS Growth
- 31.92%
- Country
- US
- Employees
- 9,983
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model
Company Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgen...
How the Company Makes Money
Concentra primarily makes money by delivering and administering occupational health services for employers and other payers across its clinic network and associated service channels. Key revenue streams generally include: (1) patient/encounter-based...
Concentra Group Holdings Parent, Inc. Earnings Call Summary
The call was strongly positive overall. Concentra reported broad-based volume and revenue growth, significant earnings and margin expansion, improved retention and market share momentum, a raised 2026 outlook, continued center expansion, debt reduction, and an improved credit profile. The main negatives were lower operating cash flow and free cash flow, a higher G&A ratio, uncertainty around 2027 fee schedules and New York timing, and management's expectation that margin expansion will moderate relative to 2026.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Concentra raised its 2026 revenue guidance to $2.36 billion to $2.38 billion and adjusted EBITDA guidance to $505 million to $510 million; its free cash flow range of $220 million to $240 million and capital expenditure range of $70 million to $80 million remains unchanged. Completed acquisitions and de novo development are expected to add 15 new centers during 2026, and the company is currently anticipating low double digit de novo openings in 2027. Management expects employer services rate growth to remain generally consistent with its long term expectation of approximately 3%, has no reason to expect aggregate workers' compensation rate growth to differ materially from its long term expectations, and expects to provide formal 2027 guidance early next year; its long term growth algorithm remains low single digit visit growth volumes, 3% rate, and low single digits on core, semi organic growth rate.
Concentra Group Holdings Parent, Inc. Financial Statement Overview
Summary
Profitability and operating trends are solid (revenue up meaningfully in TTM, gross margin expanding, and healthy net margin), and cash conversion is good with strong TTM free cash flow slightly exceeding net income. The key offset is balance-sheet risk: leverage has been high and volatile (improved in TTM but still elevated), reducing financial flexibility if margins or cash flows soften.
Income Statement
78PositiveBalance Sheet
52NeutralCash Flow
73Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.34B | 2.16B | 1.90B | 1.84B | 1.72B |
| Gross Profit | 698.76M | 613.09M | 527.98M | 512.43M | 408.19M |
| EBITDA | 478.53M | 408.93M | 368.26M | 360.15M | 330.20M |
| Net Income | 216.36M | 166.41M | 166.54M | 179.95M | 166.73M |
Balance Sheet | |||||
| Total Assets | 3.01B | 3.04B | 2.52B | 2.49B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 85.82M | 79.90M | 183.25M | 31.37M | 37.66M |
| Total Debt | 618.78M | 2.10B | 1.95B | 905.00M | 1.04B |
| Total Liabilities | 2.47B | 2.62B | 2.22B | 1.31B | 1.30B |
| Stockholders Equity | 506.98M | 393.28M | 275.67M | 1.16B | 973.32M |
Cash Flow | |||||
| Free Cash Flow | 339.74M | 197.06M | 210.35M | 164.98M | 228.35M |
| Operating Cash Flow | 326.79M | 279.40M | 274.68M | 234.32M | 274.34M |
| Investing Cash Flow | -75.06M | -414.86M | -71.27M | -75.31M | -57.75M |
| Financing Cash Flow | -215.86M | 32.10M | -51.53M | -165.29M | -209.86M |
Concentra Group Holdings Parent, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 42.15 is above the 20-day moving average (MA) of 39.56, above the 50-day MA of 36.85, and above the 200-day MA of 28.83, indicating a bullish trend. The MACD of 1.49 indicates Negative momentum. The RSI at 66.07 is Neutral, neither overbought nor oversold. The STOCH value of 67.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.
Concentra Group Holdings Parent, Inc. Risk Analysis
Concentra Group Holdings Parent, Inc. disclosed 63 risk factors in its most recent earnings report. Concentra Group Holdings Parent, Inc. reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksConcentra Group Holdings Parent, Inc. Peers Comparison
Overall Rating
UHS76Outperform- CON75Outperform
USPH67Neutral
HCA64Neutral
STLN50Neutral
DCGO39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| UHS | 76Outperform | $11.58B | 8.24 | 19.54% | 0.40% | 8.00% | 13.14% |
| CON | 75Outperform | $5.55B | 24.86 | 47.30% | 0.59% | 14.02% | 31.92% |
| USPH | 67Neutral | $1.33B | -72.00 | -1.27% | 1.88% | 11.32% | -92.59% |
| HCA | 64Neutral | $106.68B | 16.77 | -100.45% | 0.60% | 5.82% | 16.59% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| STLN | 50Neutral | $693.88M | -23.10 | 209.81% | ― | 38.38% | 54.91% |
| DCGO | 39Underperform | $25.80M | -0.12 | -115.58% | ― | -32.40% | -969.05% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CON | Concentra Group Holdings Parent, Inc. | 42.15 | 23.00 | 120.15% | |
| HCA | Hca Healthcare | 507.48 | 34.11 | 7.21% | |
| USPH | U.s. Physical Therapy | 97.20 | 25.19 | 34.98% | |
| UHS | Universal Health Services | 198.59 | -29.65 | -12.99% | |
| STLN | Starling Oncology Institute, Inc. | 6.70 | 3.16 | 89.27% | |
| DCGO | DocGo, Inc. | 0.24 | -0.87 | -78.11% |
Concentra Group Holdings Parent, Inc. Corporate Events
Concentra Reports Strong Third-Quarter Results and Growth
PositiveOn November 5, 2026, Concentra reported third-quarter revenue of $622.1 million, up 8.6% year over year, while net income attributable to the Company rose 36.5% to $65.9 million and Adjusted EBITDA increased 17.9% to $140.2 million. Patient visits gr...
Concentra Announces CFO Appointment Amid Leadership Succession
PositiveConcentra announced on September 8, 2026, that Tanner Newton, currently senior vice president of strategy and finance, will become executive vice president and chief financial officer effective November 1, 2026. He will report to Matt DiCanio, who is...
Concentra Announces Insider Share Repurchase Agreement Completion
PositiveOn August 21, 2026, Concentra Group Holdings Parent, Inc. agreed to repurchase 1,000,000 shares of its common stock from chairman Robert A. Ortenzio and related entities in a privately negotiated transaction at $34.65 per share, a 1% discount to that...
Concentra Raises 2026 Guidance After Strong Q2 Results
PositiveConcentra reported strong second-quarter 2026 results on August 6, 2026, with revenue up 10.0% to $606.0 million and net income rising 45.7% to $67.3 million. Adjusted EBITDA grew 22.5% to $140.9 million, supported by higher revenue per visit, increa...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026